title: Assessment of hypervolemia by cyclic 3'5'-guanosine monophosphate in pediatric patients on hemodialysis.
authors.forename: T
authors.initials: T
authors.lastname: Sitter
authors.forename: V
authors.initials: V
authors.lastname: Holzgartner
authors.forename: G
authors.initials: G
authors.lastname: Wolfram
authors.forename: M
authors.initials: M
authors.lastname: Toepfer
authors.forename: B
authors.initials: B
authors.lastname: Klare
authors.forename: R
authors.initials: R
authors.lastname: Gerzer
authors.forename: H
authors.initials: H
authors.lastname: Schiffl
mesh_terms: D000293:Adolescent; D000328:Adult; D001810:Blood Volume; D001835:Body Weight; D002648:Child; D006152:Cyclic GMP / Q000097:blood*; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000503:physiopathology / Q000628:therapy*; D008137:Longitudinal Studies; D008297:Male; D011446:Prospective Studies; D006435:Renal Dialysis / Q000009:adverse effects*; D014883:Water-Electrolyte Imbalance / Q000097:blood / Q000175:diagnosis*
chemical_list: D006152:Cyclic GMP